New Zealand markets open in 3 hours 27 minutes

LLY Jun 2024 710.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
66.60-10.95 (-14.12%)
As of 09:59AM EDT. Market open.
Full screen
Previous close77.55
Open66.60
Bid65.85
Ask67.70
Strike710.00
Expiry date2024-06-21
Day's range66.60 - 66.60
Contract rangeN/A
Volume1
Open interest350
  • PR Newswire

    Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement

    Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2024 financial results on April 30, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.

  • Insider Monkey

    Jim Cramer is Recommending These 10 Stocks in April

    In this article, we will take a detailed look at Jim Cramer is Recommending These 10 Stocks in April. For a quick overview of such stocks, read our article Jim Cramer is Recommending These 5 Stocks in April. Jim Cramer has been sharing his thoughts about the latest market pullback on his programs on CNBC. Last week, Cramer said […]

  • Reuters

    More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm

    The cybersecurity firm BrandShield has taken down more than 250 websites selling fake versions of popular weight-loss and diabetes drugs in the GLP-1 class, the company’s CEO Yoav Keren told Reuters. BrandShield, which shared this information exclusively with Reuters, said that out of the 279 pharmacy websites the company closed last year for selling drugs intended to treat metabolic conditions, more than 90% were related to GLP-1 medicines, according to Keren. Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound are GLP-1 drugs, which were developed for type 2 diabetes but also reduce food cravings and cause the stomach to empty more slowly.